Yesterday, after the closing bell, the company announced 1st quarter 2010 expectations, and they were better than originally expected. The company anticipates earnings per share before special items and tax adjustments of approximately $0.15 for first quarter 2010 versus First Call Consensus Estimate of $0.09. Furthermore, positive impact of new business gains and improving demand dynamics expected to drive revenues above $600M for first quarter of 2010.
Fresenius Kabi Pharmaceuticals Holding Inc (NASDAQ:APCVZ) is trading at $0.43 up $0.255 or 145% on heavy volume of 12M
There is no news on this stock today but there seems to be something going on as it is trading at a ridiculous volume. We will keep you informed on this one as the day goes on.
No comments:
Post a Comment